Indonesia
11 Vaccines Approved for Use in Indonesia
Protein Subunit
Serum Institute of India
COVOVAX (Novavax formulation)
Approved in 5 countries
3 trials in 1 country
Approval Source: reuters.com
Protein Subunit
Anhui Zhifei Longcom
Zifivax
Approved in 4 countries
20 trials in 5 countries
Approval Source: reuters.com
RNA
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Non Replicating Viral Vector
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Approval Source: reuters.com
Inactivated
Shenzhen Kangtai Biological Products Co
KCONVAC
Approved in 2 countries
7 trials in 1 country
Approval Source: barrons.com
Inactivated
Sinopharm (Beijing)
Covilo
Approved in 91 countries
29 trials in 12 countries
Approval Source: reuters.com
Inactivated
10 in Clinical Trials in Indonesia
Protein Subunit
Anhui Zhifei Longcom
Zifivax
Approved in 4 countries
20 trials in 5 countries
Protein Subunit
West China Hospital
Recombinant (Sf9 cell)
7 trials in 4 countries
RNA
Walvax
mRNA
4 trials in 3 countries
Non Replicating Viral Vector
ReiThera
GRAd-COV2
5 trials in 12 countries
Inactivated
Sinovac
CoronaVac
Approved in 56 countries
37 trials in 9 countries
Protein Subunit
Adimmune Corporation
AdimrSC-2f
3 trials in 2 countries
Protein Subunit
PT Bio Farma
SARS-CoV-2 Protein Subunit Recombinant Vaccine
4 trials in 1 country
Replicating Viral Vector
Aivita Biomedical Inc
AV-COVID-19
4 trials in 2 countries
Inactivated
Airlangga University
UNAIR Inactivated COVID-19 Vaccine
2 trials in 1 country
Protein Subunit
PT Bio Farma